{
  "case_id": "Case_5",
  "model_id": "ai21/jamba-large-1.7",
  "content": "{\n    \"primary_diagnosis\": {\n        \"name\": \"Parkinson's Disease\",\n        \"confidence\": 0.7,\n        \"icd_code\": \"G20\",\n        \"reasoning\": \"The patient presents with classic symptoms of tremor, bradykinesia, and rigidity. The brain MRI showing subtle basal ganglia abnormalities supports a diagnosis of a neurodegenerative disorder, and Parkinson's Disease is the most likely cause given the progressive nature of the symptoms and absence of other significant findings.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"Essential Tremor\",\n            \"confidence\": 0.5,\n            \"icd_code\": \"G25.0\",\n            \"reasoning\": \"Essential Tremor could explain the tremor, but the combination with bradykinesia and rigidity makes this less likely. Also, Essential Tremor typically does not present with basal ganglia abnormalities on MRI.\"\n        },\n        {\n            \"name\": \"Multiple System Atrophy\",\n            \"confidence\": 0.4,\n            \"icd_code\": \"G90.3\",\n            \"reasoning\": \"Multiple System Atrophy (MSA) can present with Parkinsonian symptoms and MRI abnormalities, but it usually progresses more rapidly than Parkinson's Disease and often involves autonomic dysfunction, which is not mentioned here.\"\n        },\n        {\n            \"name\": \"Toxic Encephalopathy\",\n            \"confidence\": 0.3,\n            \"icd_code\": \"G92\",\n            \"reasoning\": \"Given the patient's recent work in rural Bangladesh and potential exposure to environmental toxins, a toxic encephalopathy could be considered. However, the temporal relationship and lack of specific toxicology findings reduce its likelihood.\"\n        }\n    ],\n    \"key_findings\": [\n        \"Tremor, bradykinesia, rigidity\",\n        \"Subtle basal ganglia abnormalities on MRI\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Dopamine Transporter (DaT) Scan\",\n            \"purpose\": \"Rule out/confirm Parkinsonian syndromes\",\n            \"priority\": \"routine\"\n        },\n        {\n            \"test\": \"Toxicology Screening\",\n            \"purpose\": \"Rule out environmental toxin exposure\",\n            \"priority\": \"routine\"\n        },\n        {\n            \"test\": \"Genetic Testing for Parkinson's\",\n            \"purpose\": \"Exclude genetic forms of Parkinson's Disease\",\n            \"priority\": \"routine\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Refer to neurologist for further evaluation\",\n            \"Discuss potential environmental exposure risks with patient\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Carbidopa-Levodopa\",\n                \"dose\": \"25/100 mg three times daily\",\n                \"route\": \"PO\",\n                \"duration\": \"Ongoing\",\n                \"rationale\": \"To alleviate motor symptoms of Parkinson's Disease\"\n            }\n        ],\n        \"monitoring\": [\n            \"Monitor for medication side effects\",\n            \"Monthly follow-up initially\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Neurology\",\n                \"urgency\": \"routine\",\n                \"reason\": \"To confirm diagnosis and manage Parkinsonian symptoms\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Rapid progression of symptoms\",\n        \"Autonomic dysfunction (e.g., orthostatic hypotension)\"\n    ],\n    \"patient_education\": [\n        \"Understanding of Parkinson's Disease and its management\",\n        \"Importance of follow-up and adherence to treatment\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"Monthly initially, then every 3-6 months\",\n        \"conditions\": \"Increased symptom severity, new neurological symptoms\"\n    },\n    \"confidence_in_assessment\": 0.8,\n    \"uncertainties\": [\n        \"Exact cause of basal ganglia abnormalities\",\n        \"Influence of environmental exposure on disease progression\"\n    ]\n}",
  "latency": 20.321542263031006,
  "timestamp": "2025-08-10T01:19:33.974212",
  "cached_at": "2025-08-10T01:19:33.974217"
}